The role of adipose tissue and adipokines in obesity-related inflammatory diseases

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Balistreri, Carmela Rita ^a   Caruso, Calogero ^a   Candore, Giuseppina ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPSIN; ANGIOTENSINOGEN; APELIN; C REACTIVE PROTEIN; GLUCOCORTICOID; GLUCOSE TRANSPORTER 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; RESISTIN; RETINOL BINDING PROTEIN 4; SECRETORY PROTEIN; SERINE PROTEINASE INHIBITOR; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASPIN;

ADIPOSE TISSUE; ALZHEIMER DISEASE; ANGIOGENESIS; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CEREBROVASCULAR DISEASE; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME INDUCTION; FEVER; GLUCOSE HOMEOSTASIS; GLYCATION; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOLYSIS; MACROPHAGE; MALNUTRITION; METABOLIC SYNDROME X; METABOLISM; OBESITY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR DOWN REGULATION; REVIEW; SMOOTH MUSCLE FIBER; STRESS; STROKE; TRIACYLGLYCEROL BLOOD LEVEL; AGING; HUMAN; IMMUNOLOGY; INFLAMMATION; OVERNUTRITION; PHYSIOLOGY;

ADIPOKINES; ADIPOSE TISSUE; AGING; HUMANS; INFLAMMATION; OBESITY; OVERNUTRITION;

EID: 77955404414     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/802078     Document Type: Review

References (187)

1. International Obesity Taskforce. 2005, http://www.iotf.org/
2. Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M., Prevalence of overweight and obesity in the United States, 19992004 Journal of the American Medical Association 2006 295 13 1549 1555
3. Pengelly C. D., Morris J., Body mass index and weight distribution Scottish Medical Journal 2009 54 3 17 21
4. Dehghan M., Akhtar-Danesh N., Merchant A. T., Childhood obesity, prevalence and prevention Nutrition Journal 2005 4, article 24
5. Ben-Sefer E., Ben-Natan M., Ehrenfeld M., Childhood obesity: current literature, policy and implications for practice International Nursing Review 2009 56 2 166 173
6. Schelbert K. B., Comorbidities of obesity Primary Care 2009 36 2 271 285
7. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- : direct role in obesity-linked insulin resistance Science 1993 259 5091 87 91
8. Wozniak S. E., Gee L. L., Wachtel M. S., Frezza E. E., Adipose tissue: the new endocrine organ? a review article Digestive Diseases and Sciences 2009 54 9 1847 1856
9. Gesta S., Tseng Y.-H., Kahn C. R., Developmental origin of fat: tracking obesity to its source Cell 2007 131 2 242 256
10. Juge-Aubry C. E., Henrichot E., Meier C. A., Adipose tissue: a regulator of inflammation Best Practice Research. Clinical Endocrinology Metabolism 2005 19 4 547 566
11. Cancello R., Clment K., Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue International Journal of Obstetrics Gynaecology 2006 113 10 1141 1147
12. Lafontan M., Berlan M., Do regional differences in adipocyte biology provide new pathophysiological insights? Trends in Pharmacological Sciences 2003 24 6 276 283
13. Gesta S., Blhet M., Yamamoto Y., Norris A. W., Berndt J., Kralisch S., Boucher J., Lewis C., Kahn C. R., Evidence for a role of developmental genes in the origin of obesity and body fat distribution Proceedings of the National Academy of Sciences of the United States of America 2006 103 17 6676 6681
14. Vidal H., Gene expression in visceral and subcutaneous adipose tissues Annals of Medicine 2001 33 8 547 555
15. Vohl M.-C., Sladek R., Robitaille J., Gurd S., Marceau P., Richard D., Hudson T. J., Tchernof A., A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men Obesity Research 2004 12 8 1217 1222
16. Subramanian V., Ferrante A. W. Jr., Obesity, inflammation, and macrophages Nestle Nutrition Workshop Series. Paediatric Programme 2009 63 151 162, 259268
17. Fantuzzi G., Adiponectin and inflammation: consensus and controversy Journal of Allergy and Clinical Immunology 2008 121 2 326 330
18. Lago F., Dieguez C., Gmez-Reino J., Gualillo O., Adipokines as emerging mediators of immune response and inflammation Nature Clinical Practice Rheumatology 2007 3 12 716 724 (Pubitemid 350187017)
19. Lago F., Gmez R., Gmez-Reino J. J., Dieguez C., Gualillo O., Adipokines as novel modulators of lipid metabolism Trends in Biochemical Sciences 2009 34 10 500 510
20. Chudek J., Wicek A., Adipose tissue, inflammation and endothelial dysfunction Pharmacological Reports 2006 58 81 88
21. Zeyda M., Stulnig T. M., Adipose tissue macrophages Immunology Letters 2007 112 2 61 67
22. Redinger R. N., Fat storage and the biology of energy expenditure Translational Research 2009 154 2 52 60
23. Frhbeck G., Becerril S., Sinz N., Garrastachu P., Garca-Velloso M. J., BAT: a new target for human obesity? Trends in Pharmacological Sciences 2009 30 8 387 396
24. Virtanen K. A., Lidell M. E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N.-J., Enerbck S., Nuutila P., Functional brown adipose tissue in healthy adults New England Journal of Medicine 2009 360 15 1518 1525
25. Morton G. J., Cummings D. E., Baskin D. G., Barsh G. S., Schwartz M. W., Central nervous system control of food intake and body weight Nature 2006 443 7109 289 295
26. Kreier F., Fliers E., Voshol P. J., Van Eden C. G., Havekes L. M., Kalsbeek A., Van Heijningen C. L., Sluiter A. A., Mettenleiter T. C., Romijn J. A., Sauerwein H. P., Buijs R. M., Selective parasympathetic innervation of subcutaneous and intra-abdominal fatfunctional implications Journal of Clinical Investigation 2002 110 9 1243 1250
27. Schwartz M. W., Woods S. C., Porte D. Jr., Seeley R. J., Baskin D. G., Central nervous system control of food intake Nature 2000 404 6778 661 671
28. Robidoux J., Martin T. L., Collins S., β-adrenergic receptors and regulation of energy expenditure: a family affair Annual Review of Pharmacology and Toxicology 2004 44 297 323
29. Karalis K. P., Giannogonas P., Kodela E., Koutmani Y., Zoumakis M., Teli T., Mechanisms of obesity and related pathology: linking immune responses to metabolic stress FEBS Journal 2009 276 20 5747 5754
30. Maggini S., Wintergerst E. S., Beveridge S., Hornig D. H., Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses British Journal of Nutrition 2007 98 supplement 1 29 35
31. Hotamisligil G. S., Erbay E., Nutrient sensing and inflammation in metabolic diseases Nature Reviews Immunology 2008 8 12 923 934
32. Chrousos G. P., Gold P. W., The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis Journal of the American Medical Association 1992 267 9 1244 1252
33. Purnell J. Q., Kahn S. E., Samuels M. H., Brandon D., Loriaux D. L., Brunzell J. D., Enhanced cortisol production rates, free cortisol, and 11-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss American Journal of Physiology 2009 296 2 E351 E357
34. Gordon S., Macrophage heterogeneity and tissue lipids Journal of Clinical Investigation 2007 117 1 89 93
35. Lumeng C. N., DelProposto J. B., Westcott D. J., Saltiel A. R., Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes Diabetes 2008 57 12 3239 3246
36. Moller D. E., Berger J. P., Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation International Journal of Obesity and Related Metabolic Disorders 2003 27 supplement 3 17 21
37. Joseph S. B., Castrillo A., Laffitte B. A., Mangelsdorf D. J., Tontonoz P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors Nature Medicine 2003 9 2 213 219
38. Zhang J., Wu Y., Zhang Y., Leroith D., Bernlohr D. A., Chen X., The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages Molecular Endocrinology 2008 22 6 1416 1426
39. Spalding K. L., Arner E., Westermark P. O., Bernard S., Buchholz B. A., Bergmann O., Blomqvist L., Hoffstedt J., Nslund E., Britton T., Concha H., Hassan M., Rydn M., Frisn J., Arner P., Dynamics of fat cell turnover in humans Nature 2008 453 7196 783 787
40. Bourlier V., Zakaroff-Girard A., Miranville A., De Barros S., Maumus M., Sengenes C., Galitzky J., Lafontan M., Karpe F., Frayn K. N., Bouloumi A., Remodeling phenotype of human subcutaneous adipose tissue macrophages Circulation 2008 117 6 806 815
41. Faust I. M., Johnson P. R., Stern J. S., Hirsch J., Diet-induced adipocyte number increase in adult rats: a new model of obesity American Journal of Physiology 1978 235 3 E279 E286
42. Henegar C., Tordjman J., Achard V., Lacasa D., Cremer I., Guerre-Millo M., Poitou C., Basdevant A., Stich V., Viguerie N., Langin D., Bedossa P., Zucker J.-D., Clement K., Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity Genome Biology 2008 9 1, article R14
43. Jerns M., Palming J., Sjholm K., Jennische E., Svensson P. A., Gabrielsson B. G., Levin M., Sjgren A., Rudemo M., Lystig T. C., Carlsson B., Carlsson L. M., Lnn M., Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression FASEB Journal 2006 20 9 1540 1542
44. Maury E., Ehala-Aleksejev K., Guiot Y., Detry R., Vandenhooft A., Brichard S. M., Adipokines oversecreted by omental adipose tissue in human obesity American Journal of Physiology 2007 293 3 E656 E665
45. Skurk T., Alberti-Huber C., Herder C., Hauner H., Relationship between adipocyte size and adipokine expression and secretion Journal of Clinical Endocrinology and Metabolism 2007 92 3 1023 1033
46. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J. L., Hugol D., Coussieu C., Basdevant A., Hen A. B., Bedossa P., Guerre-Millo M., Clment K., Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 2006 55 6 1554 1561
47. Harman-Boehm I., Blher M., Redel H., Sion-Vardy N., Ovadia S., Avinoach E., Shai I., Klting N., Stumvoll M., Bashan N., Rudich A., Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity Journal of Clinical Endocrinology and Metabolism 2007 92 6 2240 2247
48. Sengens C., Miranville A., Lolmde K., Curat C. A., Bouloumi A., The role of endothelial cells in inflamed adipose tissue Journal of Internal Medicine 2007 262 4 415 421
49. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 2003 112 12 1796 1808
50. Huber J., Kiefer F. W., Zeyda M., Ludvik B., Silberhumer G. R., Prager G., Zlabinger G. J., Stulnig T. M., CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity Journal of Clinical Endocrinology and Metabolism 2008 93 8 3215 3221
51. Cinti S., Mitchell G., Barbatelli G., Murano I., Ceresi E., Faloia E., Wang S., Fortier M., Greenberg A. S., Obin M. S., Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans Journal of Lipid Research 2005 46 11 2347 2355
52. Maury E., Brichard S. M., Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome Molecular and Cellular Endocrinology 2010 314 1 1 16
53. Trayhurn P., Wang B., Wood I. S., Hypoxia in adipose tissue: a basis for the dysregulation of tissue function in obesity? British Journal of Nutrition 2008 100 2 227 235
54. Wang B., Wood I. S., Trayhurn P., Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes Pflugers Archiv 2007 455 3 479 492 (Pubitemid 47624196)
55. Ye J., Emerging role of adipose tissue hypoxia in obesity and insulin resistance International Journal of Obesity 2009 33 1 54 66
56. Luo N., Liu J., Chung B. H., Yang Q., Klein R. L., Timothy Garvey W., Fu Y., Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis Diabetes 2010 59 4 791 799
57. Law I. K. M., Xu A., Lam K. S. L., Berger T., Mak T. W., Vanhoutte P. M., Liu J. T.C., Sweeney G., Zhou M., Yang B., Wang Y., Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity Diabetes 2010 59 4 872 882
58. Esteve E., Ricart W., Fernndez-Real J. M., Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin Diabetes Care 2009 32 supplement 2 362 367
59. Cnop M., Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes Biochemical Society Transactions 2008 36 3 348 352
60. Ghanim H., Mohanty P., Deopurkar R., Sia C. L., Korzeniewski K., Abuaysheh S., Chaudhuri A., Dandona P., Acute modulation of Toll-like receptors by insulin Diabetes Care 2008 31 9 1827 1831
61. Vitseva O. I., Tanriverdi K., Tchkonia T. T., Kirkland J. L., McDonnell M. E., Apovian C. M., Freedman J., Gokce N., Inducible Toll-like receptor and NF- B regulatory pathway expression in human adipose tissue Obesity 2008 16 5 932 937
62. Balistreri C. R., Colonna-Romano G., Lio D., Candore G., Caruso C., TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases Journal of Clinical Immunology 2009 29 4 406 415
63. Cani P. D., Bibiloni R., Knauf C., Waget A., Neyrinck A. M., Delzenne N. M., Burcelin R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 2008 57 6 1470 1481
64. Leuwer M., Welters I., Marx G., Rushton A., Bao H., Hunter L., Trayhurn P., Endotoxaemia leads to major increases in inflammatory adipokine gene expression in white adipose tissue of mice Pflugers Archiv 2009 457 4 731 741
65. Nguyen M. T. A., Satoh H., Favelyukis S., Babendure J. L., Imamura T., Sbodio J. I., Zalevsky J., Dahiyat B. I., Chi N.-W., Olefsky J. M., JNK and tumor necrosis factor- mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes Journal of Biological Chemistry 2005 280 42 35361 35371
66. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025
67. Nguyen M. T. A., Favelyukis S., Nguyen A.-K., Reichart D., Scott P. A., Jenn A., Liu-Bryan R., Glass C. K., Neels J. G., Olefsky J. M., A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways Journal of Biological Chemistry 2007 282 48 35279 35292
68. Suganami T., Mieda T., Itoh M., Shimoda Y., Kamei Y., Ogawa Y., Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation Biochemical and Biophysical Research Communications 2007 354 1 45 49
69. Jiao P., Chen Q., Shah S., Du J., Tao B., Tzameli I., Yan W., Xu H., Obesity-related upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor- B and c-Jun NH2-terminal kinase pathways Diabetes 2009 58 1 104 115
70. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 2006 440 7086 944 948
71. Shoelson S. E., Lee J., Yuan M., Inflammation and the IKK /I B/NF- B axis in obesity- and diet-induced insulin resistance International Journal of Obesity and Related Metabolic Disorders 2003 27 supplement 3 49 52
72. Rui L., Yuan M., Frantz D., Shoelson S., White M. F., SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2 Journal of Biological Chemistry 2002 277 44 42394 42398
73. Mooney R. A., Senn J., Cameron S., Inamdar N., Boivin L. M., Shang Y., Furlanetto R. W., Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor: a potential mechanism for cytokine-mediated insulin resistance Journal of Biological Chemistry 2001 276 28 25889 25893
74. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes Journal of Clinical Investigation 2005 115 5 1111 1119
75. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults New England Journal of Medicine 2003 348 17 1625 1638
76. Freedland S. J., Obesity and prostate cancer: importance of race and stage of disease Journal of Urology 2007 178 5 1842 1843
77. Abrahamson P. E., Gammon M. D., Lund M. J., Flagg E. W., Porter P. L., Stevens J., Swanson C. A., Brinton L. A., Eley J. W., Coates R. J., General and abdominal obesity and survival among young women with breast cancer Cancer Epidemiology Biomarkers and Prevention 2006 15 10 1871 1877
78. Samanic C., Chow W.-H., Gridley G., Jarvholm B., Fraumeni J. F. Jr., Relation of body mass index to cancer risk in 362,552 Swedish men Cancer Causes and Control 2006 17 7 901 909
79. Dignam J. J., Polite B. N., Yothers G., Raich P., Colangelo L., O'Connell M. J., Wolmark N., Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer Journal of the National Cancer Institute 2006 98 22 1647 1654
80. Pavelka J. C., Brown R. S., Karlan B. Y., Cass I., Leuchter R. S., Lagasse L. O., Li A. J., Effect of obesity on survival in epithelial ovarian cancer Cancer 2006 107 7 1520 1524
81. Chia V. M., Newcomb P. A., Trentham-Dietz A., Hampton J. M., Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis International Journal of Gynecological Cancer 2007 17 2 441 446
82. Huffman D. M., Barzilai N., Role of visceral adipose tissue in aging Biochimica et Biophysica Acta 2009 1790 10 1117 1123
83. Whitmer R. A., Gustafson D. R., Barrett-Connor E., Haan M. N., Gunderson E. P., Yaffe K., Central obesity and increased risk of dementia more than three decades later Neurology 2008 71 14 1057 1064
84. Razay G., Vreugdenhil A., Wilcock G., Obesity, abdominal obesity and Alzheimer disease Dementia and Geriatric Cognitive Disorders 2006 22 2 173 176
85. Guallar-Castilln P., Sagardui-Villamor J., Banegas J. R., Graciani A., Forns N. S., Garca E. L., Rodrguez-Artalejo F., Waist circumference as a predictor of disability among older adults Obesity 2007 15 1 233 244
86. Fontaine K. R., Redden D. T., Wang C., Westfall A. O., Allison D. B., Years of life lost due to obesity Journal of the American Medical Association 2003 289 2 187 193
87. Valdes A. M., Andrew T., Gardner J. P., Kimura M., Oelsner E., Cherkas L. F., Aviv A., Spector T. D., Obesity, cigarette smoking, and telomere length in women Lancet 2005 366 9486 662 664
88. Stevens J., Keil J. E., Rust P. F., Tyroler H. A., Davis C. E., Gazes P. C., Body mass index and body girths as predictors of mortality in black and white women Archives of Internal Medicine 1992 152 6 1257 1262
89. Folsom A. R., Kaye S. A., Sellers T. A., Hong C.-P., Cerhan J. R., Potter J. D., Prineas R. J., Body fat distribution and 5-year risk of death in older women Journal of the American Medical Association 1993 269 4 483 487
90. Baik I., Ascherio A., Rimm E. B., Giovannucci E., Spiegelman D., Stampfer M. J., Willett W. C., Adiposity and mortality in men American Journal of Epidemiology 2000 152 3 264 271
91. Pischon T., Boeing H., Hoffmann K., Bergmann M., Schulze M. B., Overvad K., Van Der Schouw Y. T., Spencer E., Moons K. G. M., Tjnneland A., Halkjaer J., Jensen M. K., Stegger J., Clavel-Chapelon F., Boutron-Ruault M.-C., Chajes V., Linseisen J., Kaaks R., Trichopoulou A., Trichopoulos D., Bamia C., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Peeters P. H. M., May A. M., Bueno-De-Mesquita H. B., Van Duijnhoven F. J. B., Hallmans G., Weinehall L., Manjer J., Hedblad B., Lund E., Agudo A., Arriola L., Barricarte A., Navarro C., Martinez C., Quirs J. R., Key T., Bingham S., Khaw K. T., Boffetta P., Jenab M., Ferrari P., Riboli E., General and abdominal adiposity and risk of death in Europe New England Journal of Medicine 2008 359 20 2105 2120
92. Muzumdar R., Allison D. B., Huffman D. M., Ma X., Atzmon G., Einstein F. H., Fishman S., Poduval A. D., McVei T., Keith S. W., Barzilai N., Visceral adipose tissue modulates mammalian longevity Aging Cell 2008 7 3 438 440
93. Beutler B., Innate immunity: an overview Molecular Immunology 2004 40 12 845 859
94. Levin B. R., Lipsitch M., Bonhoeffer S., Population biology, evolution, and infectious disease: convergence and synthesis Science 1999 283 5403 806 809
95. Sondergaard L., Homology between the mammalian liver and Drosophila fat body Trends in Genetics 1993 9 6, article 193
96. Leclerc V., Reichhart J.-M., The immune response of Drosophila melanogaster Immunological Reviews 2004 198 59 71
97. Tong Q., Dalgin G., Xu H., Ting C.-N., Leiden J. M., Hotamisligil G. S., Function of GATA transcription factors in preadipocyte-adipocyte transition Science 2000 290 5489 134 138
98. Rusten T. E., Lindmo K., Juhsz G., Sass M., Seglen P. O., Brech A., Stenmark H., Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K Pathway Developmental Cell 2004 7 2 179 192
99. Shoelson S. E., Lee J., Goldfine A. B., Inflammation and insulin resistance Journal of Clinical Investigation 2006 116 7 1793 1801
100. Hotamisligil G. S., Inflammation and metabolic disorders Nature 2006 444 7121 860 867
101. Alberti K. G. M. M., Zimmet P., Shaw J., The metabolic syndromea new worldwide definition Lancet 2005 366 9491 1059 1062 (Pubitemid 41338752)
102. Klein S., Allison D. B., Heymsfield S. B., Kelley D. E., Leibel R. L., Nonas C., Kahn R., Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: association for weight management and obesity prevention; NAASO, the obesity society; the American society for nutrition; and the American diabetes association Diabetes Care 2007 30 6 1647 1652
103. Lorenzo C., Williams K., Hunt K. J., Haffner S. M., The national cholesterol education program-adult treatment panel III, international diabetes federation, and world health organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes Diabetes Care 2007 30 1 8 13
104. Sabio G., Das M., Mora A., Zhang Z., Jun J. Y., Hwi J. K., Barrett T., Kim J. K., Davis R. J., A stress signaling pathway in adipose tissue regulates hepatic insulin resistance Science 2008 322 5907 1539 1543
105. Kim J. H., Bachmann R. A., Chen J., Interleukin-6 and insulin resistance Vitamins and Hormones 2009 80 613 633
106. Allen T. L., Febbraio M. A., IL6 as a mediator of insulin resistance: fat or fiction? Diabetologia 2010 53 3 399 402
107. Rotter V., Nagaev I., Smith U., Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-, overexpressed in human fat cells from insulin-resistant subjects Journal of Biological Chemistry 2003 278 46 45777 45784
108. Engeli S., Schling P., Gorzelniak K., Boschmann M., Janke J., Ailhaud G., Teboul M., Massira F., Sharma A. M., The adipose-tissue renin-angiotensin- aldosterone system: role in the metabolic syndrome? International Journal of Biochemistry and Cell Biology 2003 35 6 807 825
109. Scheen A. J., Renin-angiotensin system inhibition prevents type 2 diabetes mellitus: part 1. A meta-analysis of randomised clinical trials Diabetes and Metabolism 2004 30 6 487 496
110. Calabr P., Golia E., Maddaloni V., Malvezzi M., Casillo B., Marotta C., Calabr R., Golino P., Adipose tissue-mediated inflammation: the missing link between obesity and cardiovascular disease? Internal and Emergency Medicine 2009 4 1 25 34
111. Ahima R. S., Revisiting leptin's role in obesity and weight loss Journal of Clinical Investigation 2008 118 7 2380 2383
112. Morton G. J., Blevins J. E., Williams D. L., Niswender K. D., Gelling R. W., Rhodes C. J., Baskin D. G., Schwartz M. W., Leptin action in the forebrain regulates the hindbrain response to satiety signals Journal of Clinical Investigation 2005 115 3 703 710
113. Ozcan L., Ergin A. S., Lu A., Chung J., Sarkar S., Nie D., Myers M. G. Jr., Ozcan U., Endoplasmic reticulum stress plays a central role in development of leptin resistance Cell Metabolism 2009 9 1 35 51
114. Rosenbaum M., Sy M., Pavlovich K., Leibel R. L., Hirsch J., Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli Journal of Clinical Investigation 2008 118 7 2583 2591
115. Wang Z. V., Scherer P. E., Adiponectin, cardiovascular function, and hypertension Hypertension 2008 51 1 8 14
116. Garten A., Petzold S., Barnikol-Oettler A., Krner A., Thasler W. E., Kratzsch J., Kiess W., Gebhardt R., Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes Biochemical and Biophysical Research Communications 2010 391 1 376 381
117. Imai S.-I., Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases Current Pharmaceutical Design 2009 15 1 20 28
118. Matsuzawa Y., Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease Nature Clinical Practice Cardiovascular Medicine 2006 3 1 35 42
119. Dray C., Knauf C., Daviaud D., Waget A., Boucher J., Bulon M., Cani P. D., Attan C., Guign C., Carpn C., Burcelin R., Castan-Laurell I., Valet P., Apelin stimulates glucose utilization in normal and obese insulin-resistant mice Cell Metabolism 2008 8 5 437 445
120. Zeng X. J., Zhang L. K., Wang H. X., Lu L. Q., Ma L. Q., Tang C. S., Apelin protects heart against ischemia/reperfusion injury in rat Peptides 2009 30 6 1144 1152
121. Mathieu P., Poirier P., Pibarot P., Lemieux I., Desprs J.-P., Visceral obesity the link among inflammation, hypertension, and cardiovascular disease Hypertension 2009 53 4 577 584
122. Fantuzzi G., Mazzone T., Adipose tissue and atherosclerosis: exploring the connection Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 5 996 1003
123. Yu Y.-H., Ginsberg H. N., Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue Circulation Research 2005 96 10 1042 1052
124. Gu L., Okada Y., Clinton S. K., Gerard C., Sukhova G. K., Libby P., Rollins B. J., Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice Molecular Cell 1998 2 2 275 281
125. Reilly M. P., Lehrke M., Wolfe M. L., Rohatgi A., Lazar M. A., Rader D. J., Resistin is an inflammatory marker of atherosclerosis in humans Circulation 2005 111 7 932 939
126. Verma S., Li S.-H., Wang C.-H., Fedak P. W. M., Li R.-K., Weisel R. D., Mickle D. A. G., Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction Circulation 2003 108 6 736 740
127. Kawanami D., Maemura K., Takeda N., Harada T., Nojiri T., Imai Y., Manabe I., Utsunomiya K., Nagai R., Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions Biochemical and Biophysical Research Communications 2004 314 2 415 419
128. Silswal N., Singh A. K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N. Z., Human resistin stimulates the pro-inflammatory cytokines TNF- and IL-12 in macrophages by NF- B-dependent pathway Biochemical and Biophysical Research Communications 2005 334 4 1092 1101
129. Dahl T. B., Yndestad A., Skjelland M., Ie E., Dahl A., Michelsen A., Dams J. K., Tunheim S. H., Ueland T., Smith C., Bendz B., Tonstad S., Gullestad L., Frland S. S., Krohg-Srensen K., Russell D., Aukrust P., Halvorsen B., Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 2007 115 8 972 980
130. Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., Inukai T., Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus Metabolism 2007 56 4 451 458
131. Van der Veer E., Ho C., O'Neil C., Barbosa N., Scott R., Cregan S. P., Pickering J. G., Extension of human cell lifespan by nicotinamide phosphoribosyltransferase Journal of Biological Chemistry 2007 282 15 10841 10845
132. Grisk O., Apelin and vascular dysfunction in type 2 diabetes Cardiovascular Research 2007 74 3 339 340
133. Berry M. F., Pirolli T. J., Jayasankar V., Burdick J., Morine K. J., Gardner T. J., Woo Y. J., Apelin has in vivo inotropic effects on normal and failing hearts Circulation 2004 110 11 187 193
134. Farkasfalvi K., Stagg M. A., Coppen S. R., Siedlecka U., Lee J., Soppa G. K., Marczin N., Szokodi I., Yacoub M. H., Terracciano C. M. N., Direct effects of apelin on cardiomyocyte contractility and electrophysiology Biochemical and Biophysical Research Communications 2007 357 4 889 895
135. Chong K. S., Gardner R. S., Morton J. J., Ashley E. A., McDonagh T. A., Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure European Journal of Heart Failure 2006 8 4 355 360
136. Ellinor P. T., Low A. F., MacRae C. A., Reduced apelin levels in lone atrial fibrillation European Heart Journal 2006 27 2 222 226
137. Ronkainen V.-P., Ronkainen J. J., Hnninen S. L., Leskinen H., Ruas J. L., Pereira T., Poellinger L., Vuolteenaho O., Tavi P., Hypoxia inducible factor regulates the cardiac expression and secretion of apelin FASEB Journal 2007 21 8 1821 1830
138. Atluri P., Morine K. J., Liao G. P., Panlilio C. M., Berry M. F., Hsu V. M., Hiesinger W., Cohen J. E., Woo Y. J., Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression Cellular and Molecular Biology Letters 2007 12 1 127 138
139. Bobbert T., Rochlitz H., Wegewitz U., Akpulat S., Mai K., Weickert M. O., Mhlig M., Pfeiffer A. F. H., Spranger J., Changes of adiponectin oligomer composition by moderate weight reduction Diabetes 2005 54 9 2712 2719
140. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., Okuno T., Inoue T., Node K., Tobe T., Inukai T., Nakano Y., Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin Diabetes 2006 55 7 1954 1960
141. Araki T., Emoto M., Teramura M., Yokoyama H., Mori K., Hatsuda S., Maeno T., Shinohara K., Koyama H., Shoji T., Inaba M., Nishizawa Y., Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin Metabolism 2006 55 8 996 1001
142. Ouchi N., Kihara S., Arita Y., Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF- B signaling through a cAMP-dependent pathway Circulation 2000 102 11 1296 1301
143. Motoshima H., Wu X., Mahadev K., Goldstein B. J., Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL Biochemical and Biophysical Research Communications 2004 315 2 264 271
144. Wang Y., Lam K. S. L., Xu J. Y., Lu G., Xu L. Y., Cooper G. J. S., Xu A., Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner Journal of Biological Chemistry 2005 280 18 18341 18347
145. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., Ishigami M., Kuriyama H., Kishida K., Nishizawa H., Hotta K., Muraguchi M., Ohmoto Y., Yamashita S., Funahashi T., Matsuzawa Y., Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 2001 103 8 1057 1063
146. Singh U., Devaraj S., Dasu M. R., Ciobanu D., Reusch J., Jialal I., C-Reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2469 2475
147. Devaraj S., Davis B., Simon S. I., Jialal I., CRP promotes monocyte-endothelial cell adhesion via Fc receptors in human aortic endothelial cells under static and shear flow conditions American Journal of Physiology 2006 291 3 H1170 H1176
148. Ferri C. P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P. R., Rimmer E., Scazufca M., Global prevalence of dementia: a Delphi consensus study Lancet 2005 366 9503 2112 2117
149. Vasto S., Candore G., List F., Balistreri C. R., Colonna-Romano G., Malavolta M., Lio D., Nuzzo D., Mocchegiani E., Di Bona D., Caruso C., Inflammation, genes and zinc in Alzheimer's disease Brain Research Reviews 2008 58 1 96 105
150. Strachan M. W. J., Insulin and cognitive function Lancet 2003 362 9392, article 1253
151. Farris W., Mansourian S., Chang Y., Lindsley L., Eckman E. A., Frosch M. P., Eckman C. B., Tanzi R. E., Selkoe D. J., Gunette S., Insulin-degrading enzyme regulates the levels of insulin, amyloid -protein, and the -amyloid precursor protein intracellular domain in vivo Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 4162 4167
152. Reger M. A., Watson G. S., Frey W. H. II, Baker L. D., Cholerton B., Keeling M. L., Belongia D. A., Fishel M. A., Plymate S. R., Schellenberg G. D., Cherrier M. M., Craft S., Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype Neurobiology of Aging 2006 27 3 451 458
153. Watson G. S., Bernhardt T., Reger M. A., Cholerton B. A., Baker L. D., Peskind E. R., Asthana S., Plymate S. R., Frlich L., Craft S., Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease Neurobiology of Aging 2006 27 1 38 41
154. Watson G. S., Craft S., Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease European Journal of Pharmacology 2004 490 13 97 113
155. Yamagishi S., Nakamura K., Inoue H., Kikuchi S., Takeuchi M., Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease Medical Hypotheses 2005 64 6 1205 1207
156. Candore G., Bulati M., Caruso C., Castiglia L., Colonna-Romano G., Di Bona D., Duro G., Lio D., Matranga D., Pellican M., Rizzo C., Scapagnini G., Vasto S., Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in alzheimer disease: therapeutic implications Rejuvenation Research 2010 13 2-3 301 313
157. Harvey J., Shanley L. J., O'Malley D., Irving A. J., Leptin: a potential cognitive enhancer? Biochemical Society Transactions 2005 33 5 1029 1032
158. Fewlass D. C., Noboa K., Pi-Sunyer F. X., Johnston J. M., Yan S. D., Tezapsidis N., Obesity-related leptin regulates Alzheimer's A FASEB Journal 2004 18 15 1870 1878
159. Pannacciulli N., Le D. S. N. T., Chen K., Reiman E. M., Krakoff J., Relationships between plasma leptin concentrations and human brain structure: a voxel-based morphometric study Neuroscience Letters 2007 412 3 248 253
160. Vermeer S. E., Prins N. D., den Heijer T., Hofman A., Koudstaal P. J., Breteler M. M. B., Silent brain infarcts and the risk of dementia and cognitive decline New England Journal of Medicine 2003 348 13 1215 1222
161. Honig L. S., Tang M.-X., Albert S., Costa R., Luchsinger J., Manly J., Stern Y., Mayeux R., Stroke and the risk of Alzheimer disease Archives of Neurology 2003 60 12 1707 1712
162. Honig L. S., Kukull W., Mayeux R., Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center Neurology 2005 64 3 494 500 (Pubitemid 40189869)
163. Goossens G. H., Blaak E. E., van Baak M. A., Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders Obesity Reviews 2003 4 1 43 55
164. Katzov H., Bennet A. M., Kehoe P., Wiman B., Gatz M., Blennow K., Lenhard B., Pedersen N. L., de Faire U., Prince J. A., A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Human Molecular Genetics 2004 13 21 2647 2657
165. Savaskan E., The role of the brain renin-angiotensin system in neurodegenerative disorders Current Alzheimer Research 2005 2 1 29 35
166. Albiston A. L., McDowall S. G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F. A. O., Simpson R. J., Connolly L. M., Chai S. Y., Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin-regulated aminopeptidase Journal of Biological Chemistry 2001 276 52 48623 48626
167. Notkola I.-L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., Nissinen A., Serum total cholesterol, apolipoprotein E 4 allele, and Alzheimer's disease Neuroepidemiology 1998 17 1 14 20
168. Kivipelto M., Helkala E.-L., Hnninen T., Laakso M. P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A., Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study Neurology 2001 56 12 1683 1689
169. Kalmijn S., Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies Journal of Nutrition, Health and Aging 2000 4 4 202 207
170. Tan Z. S., Seshadri S., Beiser A., Wilson P. W. F., Kiel D. P., Tocco M., D'Agostino R. B., Wolf P. A., Plasma total cholesterol level as a risk factor for Alzheimer disease the framingham study Archives of Internal Medicine 2003 163 9 1053 1057
171. Romas S. N., Tang M.-X., Berglund L., Mayeux R., APOE genotype, plasma lipids, lipoproteins, and AD in community elderly Neurology 1999 53 3 517 521
172. Yoshitake T., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Ohmori S., Nomiyama K., Kawano H., Ueda K., Sueishi K., Tsuneyoshi M., Fujishima M., Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study Neurology 1995 45 6 1161 1168
173. Reitz C., Tang M.-X., Luchsinger J., Mayeux R., Relation of plasma lipids to Alzheimer disease and vascular dementia Archives of Neurology 2004 61 5 705 714
174. Mielke M. M., Lyketsos C. G., Lipids and the pathogenesis of Alzheimer's disease: is there a link? International Review of Psychiatry 2006 18 2 173 186
175. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M. J., Cancer statistics 2008 CA Cancer Journal for Clinicians 2008 58 2 71 96
176. Caruso C., Balistreri C. R., Candore G., Carruba G., Colonna-Romano G., Di Bona D., Forte G. I., Lio D., List F., Scola L., Vasto S., Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach Cancer Immunology, Immunotherapy 2009 58 12 1919 1933
177. Vasto S., Carruba G., Lio D., Colonna-Romano G., Di Bona D., Candore G., Caruso C., Inflammation, ageing and cancer Mechanisms of Ageing and Development 2009 130 1-2 40 45
178. Vasto S., Carruba G., Candore G., Italiano E., Di Bona D., Caruso C., Inflammation and prostate cancer Future Oncology 2008 4 5 637 645
179. Sutcliffe S., Platz E. A., Inflammation and prostate cancer: a focus on infections Current Urology Reports 2008 9 3 243 249
180. Nelson W. G., De Weese T. L., De Marzo A. M., The diet, prostate inflammation, and the development of prostate cancer Cancer and Metastasis Reviews 2002 21 1 3 16
181. Carruba G., Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario Journal of Cellular Biochemistry 2007 102 4 899 911
182. Hsing A. W., Sakoda L. C., Chua S. Jr., Obesity, metabolic syndrome, and prostate cancer American Journal of Clinical Nutrition 2007 86 3 843 857
183. Yeap B. B., Testosterone and ill-health in aging men Nature Clinical Practice Endocrinology and Metabolism 2009 5 2 113 121
184. Platz E. A., Leitzmann M. F., Rifai N., Kantoff P. W., Chen Y.-C., Stampfer M. J., Willett W. C., Giovannucci E., Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era Cancer Epidemiology Biomarkers and Prevention 2005 14 5 1262 1269
185. Mistry T., Digby J. E., Desai K. M., Randeva H. S., Obesity and prostate cancer: a role for adipokines European Urology 2007 52 1 46 53
186. Candore G., Balistreri C. R., Caruso M., Grimaldi M. P., Incalcaterra E., Listi F., Vasto S., Caruso C., Pharmacogenomics: a tool to prevent and cure coronary heart disease Current Pharmaceutical Design 2007 13 36 3726 3734
187. Balistreri C. R., Grimaldi M. P., Chiappelli M., Licastro F., Castiglia L., Listi F., Vasto S., Lio D., Caruso C., Candore G., Association between the polymorphisms of TLR4 and CD14 genes and Alzheimer's disease Current Pharmaceutical Design 2008 14 26 2672 2677